Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Finally seeing short resistance with new buying interest..just needs to persist.
You may not have noticed but no one from here or old yahoo board ever saw any deal coming..ever
recently i have seen stock move down..warrants move up.
so right..warrants hardly trade.. a heavy day sees a few thousand move..the ROI is higher per dollar even at premiums..and downside resistence is stronger..people suck them up when they become available ..even at higher premiums..
value and reality are away for a while..but can be heard in the sounds of silence..nothing has ever made sense about adxs..and still doesn't..even press releases from the corporation sound as if their success is a foregone conclusion..and it all seems on track..yet shorts have created toxic otherwise lucrative investment..and these shorts don't care about covering..oh maybe some do at the margin..but the big thing is protecting self-interests and existing markets and treatments for as long as possible. but we all see whats coming..
Given low volume..this downward drift likely to continue..
the lack of share dilution which an investor might expect from a baby bio has not occured here..so shorts have nothing to cover with..After such an extented ride for shorts..it was probably a reasonable expectation that dilution would have occured..it did not so they are in a bind..but with large financial resources to help them out. ..for as long as the volume stays low..shorts accomplish nothing much..just 1 million shares covered in thirty day period..product revenue will change the equation for everyone..
shorts have been in charge and always have been..there is a vested interest in seeing the share price low..what, why or who that is..who knows..
Shorts in a bind..it would be normal to see more dilution with baby bio..but not adxs so covering has become more difficult..take downs are so obvious by now..but there is a lack of share demand after months of continued short ownership..but if we see low 8s I'll be buying..
Volume picks up on last hour and we close at or near Friday's close
Early day high..walk down....same old pattern. .
adxs lm therapy has become a superior cancer treatment on its own..so combo while a priority is more like deciding how the partner treatment improves our treatment..no one wants to recognize that as the reason for slower deal making..
adxs as a baby bio is well financed..and maintained an ingredibly low total share count..as we enter into a paid for phase 3..not to mention all the other trials.
possibility of legendary gains with minimal risk..at .40 share..i know this cannot last so I have been selling other securities to buy this one..
short interest fpr nwbo is on finra as posted..2.8 million really nothing as percent to total..
What does that mean.
Newbie
as i understand it nwbo is waiting on the phase 3 analysis of a very promising break through technology that will extend life to these brain cancer patients when nothing else will..since its at the end of phase 3..it seems very likely indeed.
the opportunity buy in is ridiculous at .43...seems like it should be about 5xs even now..
seems nwbo has a powerful solid tumor treatment technology at an affordable price.. game changer really in cancer treatment..
the only people expecting a deal are some of the long term shareholders..and god bless us all..we have waited with the patience of angels..but waiting is much easier at the circa 9 than circa 8. Thats and improvement that should not be missed in a heavily shorted stock..volume has declined to nothing on most days..and days where volume increases share price increases..the stock price is definitely being managed..but to what end..except to acquire shares to cover short positions..as evidenced by as much as 1,000,000 shares being covered the last reporting period..stock buys happen in spirts usually at the beginning..then they lazily sell back down the price..and pretty much the next day ..same thing..at this rate/volume there is a big distance to go before shorts cover..most short postions are probably buying in eventually..and may just be laughing at the evaluation..this close circuit trading system has made the fundamentals here look pretty weak on the surface..yet beneath that fascade there is a different layer..which for some strange reason is being kept extremely low key..almost secretive..whats the expression adxs is an egnima wrapped in a mystery..no doubt..but addicting and compelling..as well.
New investor..this looks like an amazing situation with lots of upside and little down side at these crazy prices for phase 3 nearing completion....
business plan is to research develop and sell constructs to different big pharmas..don't see why we could not partner with Merk, astra and amgen..different constructs for different purposes/combos..or partner the same construct as part of different combos...
over 8 million short shares left and able to cover less than one million in the last 30 day reporting period..and the cusp of dramatic market re-evaluation what to do but try and convice existing and perspective investors of the greedy management that will steal away all the potential capital gains..been going on for over 2 years now..but we never tire of looking for love in all the wrong places..and responding to too many faces..
ignatius..at some point shareholder value must be tied to management compensation..and not solely future expectations..at what point will that relationship take hold in your opinion.
fbg..yes yes market response..any new benefit package approval must be tied to market approval.
fbg don't get me wrong..i like others appreciate your deligence ..but in the end i can only assess DOCs effectiveness based on the price i bought in and the current value..those who purchased in the teens twenties and thirties may have a different view no doubt..but like you I am counting on future evaluation being much higher..esp if you look at all the progress that has been made..only thing that really matters now is phase 3 and commercialization..and keeping dilution at a minimum..
fbg, the fact management wants more ownership as compensation is very bullish..yet you manage to turn it into some sort of share grab conspiracy theory..while i have just a modest 16000+ shares and warrants i am very happy to date with the investment..and the positive returns i have seen since nov 2014 when i bought most of what i own..and am even more excited about the future under DOCs leadership..
fbg in 2014 i bought most of my holding for 2.7x per share..now they are exremely undervalued at 9.00,,warrants were 1.00 now they are a steal at 5.00 plus..what kind of shareholder return would you like to see....and what alt investment would have given a better return..facts no more armchair second guessing management conspiracy theory..
to get the deal DO wants there will be a market expression of why it should be approved..
nice expression of the account vs endgame perspective
shorts have been able to cover less than 1 million shares at this price over the last 30 reporting days..the expectations are positive as very few shares have traded ownership..this expectation for the stock will eventually spill over to wall street awareness..but short term another serious short attack..but it will fail...
First 30 min of trading.
Good vol with spike to 9.30
Now just walk down..maybe vol picks up end of day. But good cover stragedy slowly covering keeping price down.
Question of time..as someone said tic toc
And revenue generated before fda formal approval..as in Amgen and several other early licensing deals.
Short interest down again..but trying to cover with these prices..not happening fast enough..will see price rise as some retail need to cover now or near future
Stated vision to remain ressarch focused while licensing constructs for use and distribution to other pharmas.
Small demand increase should render big price increase..tittering.
Classic day trader take down..its weak.
Back in 9s before close..
Yes just everyone is buzzing about this lol.
pre market 4 shares @9.15..anyone want to decode..another push the s/p down day..buying op approaching by end of week.. low 8s.
Shorts shaking shares..still no share demand from investors..what will it take..